SMTL ID : 3wyl.1 (1 other biounit)

Crystal structure of the catalytic domain of PDE10A complexed with 5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)-1-(3-(trifluoromethyl)phenyl)pyridazin-4(1H)-one

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.68 Å
Oligo State
monomer
Ligands
1 x ZN: ZINC ION(Non-covalent)
1 x MG: MAGNESIUM ION(Non-covalent)
1 x 3KB: 5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)-1-[3-(trifluoromethyl)phenyl]pyridazin-4(1H)-one(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Kunitomo, J. et al., Discovery of 1-[2-fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one (TAK-063), a highly potent, selective, and orally active phosphodiesterase 10A (PDE10A) inhibitor. J.Med.Chem. (2014)
Release Date
2014-11-19
Peptides
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A

Related Entries With Identical Sequence

3wyk.1 | 3wyk.2 | 3wyk.3 | 3wyl.2 | 3wym.1 | 3wym.2 | 3wym.3 | 4ddl.1 | 4ddl.2 | 4p0n.1 | 4p0n.2 | 4p1r.1 | 4p1r.2 | 5axp.1 | 5axp.2 | 5axq.1 | 5axq.2 | 5b4k.1 | 5b4k.2 | 5b4l.1 | 5b4l.2